Comparison Between 1st Generation Egfr Tyrosine Kinase Inhibitor (Gefitinib) Versus 2nd Generation (Afatinib) In Egfr-Mutated Non-Small Cell Lung Cancers (Nsclc) - Real World Experience
LUNG CANCER(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要